Sentro Pharma & Health Care Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Sentro Pharma & Health Care Llp
Sentro Pharma & Health Care Llp (SPHCL) is 4 Year, 7 Months old Limited Liability Partnership 19 June 2020. Its registered office is in New Delhi, Delhi, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAS-6682
-
Incorporation Date
19 Jun 2020
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Delhi
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Sentro Pharma & Health Care Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Rao
|
Designated Partner | 19-Jun-2020 | Current |
|
Sanjeev Singhai
|
Designated Partner | 05-Dec-2022 | Current |
|
Manisha Singhai
|
Designated Partner | 27-Sep-2023 | Current |
Financial Performance of Sentro Pharma & Health Care Llp.
Sentro Pharma & Health Care Llp, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sentro Pharma & Health Care Llp?
Unlock access to Sentro Pharma & Health Care Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Delmos Enterprises LlpNaveen Rao is a mutual person
-
One-O-One Infraspace Private Limited
Naveen Rao is a mutual person
-
Delmos World Private Limited
Naveen Rao is a mutual person
-
Vedanta Computech Private Limited
Naveen Rao is a mutual person
-
Beehive Logistics Private Limited
Naveen Rao is a mutual person
-
Assh Infotech Private Limited
Naveen Rao is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Sentro Pharma & Health Care Llp?
Sentro Pharma & Health Care Llp has a workforce of 25 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sentro Pharma & Health Care Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sentro Pharma & Health Care Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
